|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
8 February 2021 |
|
Main ID: |
NCT04737473 |
|
Date of registration:
|
03/01/2021 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
The Comparative Efficacy and Safety of Two General Anesthesia Protocols Consisting of Fentanyl Plus Propofol Plus Rococuronium Plus Isoflurane Versus Ketamime Plus Magnesium Sulphate Plus Lidocaine Plus Clonidine Plus Propofol Plus Rococuronium Plus Isoflurane for Gynaecology Surgery in Cameroon
OFA-AFRO |
|
Scientific title:
|
General Anesthesia Usiing Fentanyl Plus Propofol Plus Rococuronium Plus Isoflurane Versus Ketamime Plus Magnesium Sulphate Plus Lidocaine Plus Clonidine Plus Propofol Plus Rococuronium Plus Isoflurane in Gynaecology Surgery |
|
Date of first enrolment:
|
January 6, 2020 |
|
Target sample size:
|
36 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://clinicaltrials.gov/show/NCT04737473 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: Double (Participant, Care Provider).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Cameroon
| | | | | | | |
|
Contacts
|
|
Name:
|
Joel Noutakdie Tochie, MD |
|
Address:
|
|
|
Telephone:
|
+237 676558825 |
|
Email:
|
joeltochie@gmail.com |
|
Affiliation:
|
|
|
|
Name:
|
Joel Noutakdie Tochie, MD |
|
Address:
|
|
|
Telephone:
|
+237 676558825 |
|
Email:
|
joeltchie@gmail.com |
|
Affiliation:
|
|
|
|
Name:
|
Jacqueline Ze Minkande, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Yaounde I |
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria :
- American Society of Anesthesiology (ASA) grade I and II patients
- Patients undergoing an elective myomectomy, hysterectomy, ovarian cystectomy or total
mastectomy.
- Patients who will be operated for benign pathologies or localized malignancies
Exclusion Criteria :
- Past history of allergy to any of the anesthetic drugs
- Refusal to consent to participate in the study
Age minimum:
21 Years
Age maximum:
70 Years
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Anesthesia
|
|
Clinical Trial
|
|
Gynecology
|
|
Opioids
|
|
Surgery
|
|
Intervention(s)
|
|
Drug: Opiod Free Anesthesia
|
|
Primary Outcome(s)
|
|
Intraoperative variables
[Time Frame: 9 months]
|
|
Secondary Outcome(s)
|
|
Postoperative variables
[Time Frame: 9 months]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|